These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33511685)

  • 1. Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention.
    M'Pembele R; Metzen D; Czychy N; Zako S; Mourikis P; Helten C; Trojovsky K; Ignatov D; Petzold T; Thienel M; Vornholz L; Bönner F; Levkau B; Zeus T; Kelm M; Dannenberg L; Polzin A
    Diabet Med; 2021 May; 38(5):e14532. PubMed ID: 33511685
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and cardiovascular clinical characteristics of Spanish women with stable ischaemic heart disease: Data from the SIRENA study.
    Gámez JM; Masmiquel L; Ripoll T; Barrios V; Anguita M;
    Diabetes Res Clin Pract; 2017 Jan; 123():82-86. PubMed ID: 28006697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of body mass index to bleeding events among patients with percutaneous coronary intervention: a meta-analysis.
    Lin GM; Li YH; Lin CL; Wang JH; Han CL
    Int J Cardiol; 2013 Oct; 168(5):4831-5. PubMed ID: 23876462
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Bleeding Outcomes After Percutaneous Coronary Intervention in Patients With Versus Without Aortic Stenosis.
    Huffman C; Torguson R; Fatemi O; Chen F; Gai J; Suddath W; Satler L; Pichard A; Waksman R
    Am J Cardiol; 2015 Oct; 116(7):1106-9. PubMed ID: 26256579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedure-related bleeding in elective percutaneous coronary interventions.
    Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
    Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease.
    Godoy LC; Ko DT; Rao V; Farkouh ME
    Prog Cardiovasc Dis; 2019; 62(4):358-363. PubMed ID: 31377224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.
    Angiolillo DJ; Baber U; Sartori S; Briguori C; Dangas G; Cohen DJ; Mehta SR; Gibson CM; Chandiramani R; Huber K; Kornowski R; Weisz G; Kunadian V; Oldroyd KG; Ya-Ling H; Kaul U; Witzenbichler B; Dudek D; Sardella G; Escaned J; Sharma S; Shlofmitz RA; Collier T; Pocock S; Mehran R
    J Am Coll Cardiol; 2020 May; 75(19):2403-2413. PubMed ID: 32240760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of transradial coronary intervention on bleeding complications in octogenarians.
    Tammam K; Ikari Y; Yoshimachi F; Saito F; Hassan W
    Cardiovasc Interv Ther; 2017 Jan; 32(1):18-23. PubMed ID: 26910467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial.
    Madhavan MV; Généreux P; Palmerini T; Caixeta A; Xu K; McAndrew TC; Francese DP; Kirtane AJ; Mehran R; Stone GW
    J Invasive Cardiol; 2015 Apr; 27(4):203-11. PubMed ID: 25840404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.
    Gao F; Zhou YJ; Shen H; Wang ZJ; Yang SW; Liu XL
    Acta Diabetol; 2013 Oct; 50(5):765-73. PubMed ID: 22907763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    Oimatsu Y; Kaikita K; Ishii M; Mitsuse T; Ito M; Arima Y; Sueta D; Takahashi A; Iwashita S; Yamamoto E; Kojima S; Hokimoto S; Tsujita K
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.
    Faridi KF; Rymer JA; Rao SV; Dai D; Wojdyla D; Yeh RW; Wang TY
    Am Heart J; 2019 Oct; 216():53-61. PubMed ID: 31401443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-based differences in bleeding and long-term adverse events after percutaneous coronary intervention in older patients with coronary artery disease.
    Xu N; Tang XF; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    J Interv Cardiol; 2018 Jun; 31(3):345-352. PubMed ID: 29490431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention/stenting: a systematic review and meta-analysis.
    Andrade JG; Deyell MW; Khoo C; Lee M; Humphries K; Cairns JA
    Can J Cardiol; 2013 Feb; 29(2):204-12. PubMed ID: 23036279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial.
    Richardt G; Maillard L; Nazzaro MS; Abdel-Wahab M; Carrié D; Iñiguez A; Garot P; Abdellaoui M; Morice MC; Foley D; Copt S; Stoll HP; Urban P
    Clin Res Cardiol; 2019 Jan; 108(1):31-38. PubMed ID: 29951803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.
    Ndrepepa G; Schulz S; Neumann FJ; Byrne RA; Hoppmann P; Cassese S; Ott I; Fusaro M; Ibrahim T; Tada T; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
    Am Heart J; 2013 Sep; 166(3):534-40. PubMed ID: 24016504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.
    Faggioni M; Baber U; Sartori S; Giustino G; Cohen DJ; Henry TD; Farhan S; Ariti C; Dangas G; Gibson M; Giacoppo D; Krucoff MW; Aquino M; Chandrasekhar J; Moliterno DJ; Colombo A; Vogel B; Chieffo A; Kini AS; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
    JACC Cardiovasc Interv; 2017 Apr; 10(7):645-654. PubMed ID: 28330641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.